garenoxacin has been researched along with Infections, Soft Tissue in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biedenbach, DJ; Jones, RN; Kirby, JT; Mutnick, AH; Pfaller, MA | 1 |
| Fritsche, TR; Jones, RN; Sader, HS | 1 |
| Citron, DM; Fernandez, H; Goldstein, EJ; Merriam, CV; Tyrrell, KL; Warren, YA | 1 |
3 other study(ies) available for garenoxacin and Infections, Soft Tissue
| Article | Year |
|---|---|
Geographic variations in garenoxacin (BMS284756) activity tested against pathogens associated with skin and soft tissue infections: report from the SENTRY Antimicrobial Surveillance Program (2000).
Topics: Anti-Infective Agents; Bacteria; Drug Resistance, Bacterial; Europe; Fluoroquinolones; Humans; Indoles; Latin America; Microbial Sensitivity Tests; North America; Population Surveillance; Quinolones; Skin Diseases, Bacterial; Soft Tissue Infections | 2002 |
Potency and spectrum of garenoxacin tested against an international collection of skin and soft tissue infection pathogens: report from the SENTRY antimicrobial surveillance program (1999-2004).
Topics: Adult; Anti-Bacterial Agents; Asia; Europe; Female; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Latin America; Male; Microbial Sensitivity Tests; North America; Pacific Ocean; Population Surveillance; Skin Diseases, Bacterial; Soft Tissue Infections | 2007 |
In vitro activities of the des-fluoro(6) Quinolone BMS-284756 against aerobic and anaerobic pathogens isolated from skin and soft tissue animal and human bite wound infections.
Topics: Animals; Anti-Infective Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bites and Stings; Cats; Dogs; Fluoroquinolones; Humans; Indoles; Microbial Sensitivity Tests; Quinolones; Skin Diseases, Infectious; Soft Tissue Infections | 2002 |